• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有β-连环蛋白和Ha-ras基因突变的小鼠中的肝癌发生

Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.

作者信息

Harada Naomoto, Oshima Hiroko, Katoh Masahiro, Tamai Yositaka, Oshima Masanobu, Taketo Makoto M

机构信息

Banyu Tsukuba Research Institute (Merck), Tsukuba, Japan.

出版信息

Cancer Res. 2004 Jan 1;64(1):48-54. doi: 10.1158/0008-5472.can-03-2123.

DOI:10.1158/0008-5472.can-03-2123
PMID:14729607
Abstract

We have established previously a mouse strain containing a mutant beta-catenin allele of which exon 3 was sandwiched by loxP sequences [Catnb(lox(ex3))]. In this mouse strain, a Wnt-activating beta-catenin mutation alone is insufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required. Here we report that hepatocellular carcinoma develops at the 100% incidence in mice with simultaneous mutations in the beta-catenin and H-ras genes that are introduced by adenovirus-mediated Cre expression. Although H-ras mutation alone rapidly causes large cell dysplasia in the hepatocytes, these cells show no autonomous growth within 1 week after infection of the Cre-adenovirus. However, simultaneous induction of an additional mutation in the beta-catenin gene causes a clonal expansion of such dysplastic cells, followed by nodular formation and development of hepatocellular carcinoma. These results indicate that beta-catenin mutations play a critical role in hepatocarcinogenesis in cooperation with another oncogene and that these mice provide a convenient model to investigate early steps of hepatocarcinogenesis.

摘要

我们先前已建立了一种小鼠品系,其含有一个突变的β-连环蛋白等位基因,该等位基因的外显子3被loxP序列夹在中间[Catnb(lox(ex3))]。在这种小鼠品系中,仅Wnt激活的β-连环蛋白突变不足以引发肝癌发生,但可能还需要额外的突变或表观遗传变化。在此我们报告,通过腺病毒介导的Cre表达引入β-连环蛋白和H-ras基因同时突变的小鼠中,肝癌的发生率为100%。尽管单独的H-ras突变会迅速导致肝细胞出现大细胞发育异常,但在感染Cre-腺病毒后1周内,这些细胞并未表现出自主生长。然而,β-连环蛋白基因中额外突变的同时诱导会导致此类发育异常细胞的克隆性扩增,随后形成结节并发展为肝癌。这些结果表明,β-连环蛋白突变与另一个癌基因协同作用在肝癌发生中起关键作用,并且这些小鼠为研究肝癌发生的早期步骤提供了一个便利的模型。

相似文献

1
Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.具有β-连环蛋白和Ha-ras基因突变的小鼠中的肝癌发生
Cancer Res. 2004 Jan 1;64(1):48-54. doi: 10.1158/0008-5472.can-03-2123.
2
Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.腺病毒介导的β-连环蛋白显性稳定突变体表达后小鼠肝脏中未发生肿瘤形成。
Cancer Res. 2002 Apr 1;62(7):1971-7.
3
Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.B6C3F1小鼠化学诱导的肝细胞肿瘤中潜在β-连环蛋白靶标细胞周期蛋白D1、c-Jun、c-Myc、E-钙黏蛋白和表皮生长因子受体的表达
Toxicol Appl Pharmacol. 2003 Jul 15;190(2):135-45. doi: 10.1016/s0041-008x(03)00170-4.
4
Genotype-phenotype relationships in hepatocellular tumors from mice and man.小鼠和人类肝细胞肿瘤中的基因型-表型关系。
Hepatology. 2005 Aug;42(2):353-61. doi: 10.1002/hep.20768.
5
Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.β-连环蛋白和AXIN I基因的突变是人类肝细胞癌发生过程中的晚期事件。
Liver Int. 2005 Feb;25(1):70-6. doi: 10.1111/j.1478-3231.2004.0995.x.
6
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.β-连环蛋白基因的体细胞突变在小鼠和人类肝细胞癌中很常见。
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51. doi: 10.1073/pnas.95.15.8847.
7
Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.β-连环蛋白的突变是化学诱导小鼠肝细胞癌发生过程中的早期事件。
Oncogene. 1999 Aug 19;18(33):4726-33. doi: 10.1038/sj.onc.1202858.
8
Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.苯巴比妥在肿瘤促进过程中的选择性压力导致β-连环蛋白突变的小鼠肝肿瘤的克隆性生长。
Oncogene. 2001 Nov 22;20(53):7812-6. doi: 10.1038/sj.onc.1204982.
9
Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.β-连环蛋白在肝细胞癌中的积聚及β-连环蛋白基因外显子3的突变
Jpn J Cancer Res. 1999 Dec;90(12):1301-9. doi: 10.1111/j.1349-7006.1999.tb00712.x.
10
beta-catenin mutations are absent in hepatocellular carcinomas of SV40 T-antigen transgenic mice.在SV40 T抗原转基因小鼠的肝细胞癌中不存在β-连环蛋白突变。
Int J Oncol. 2000 Jun;16(6):1133-6. doi: 10.3892/ijo.16.6.1133.

引用本文的文献

1
The ubiquitin code of RAS proteins: Decoding its role in cancer progression.RAS蛋白的泛素密码:解读其在癌症进展中的作用。
iScience. 2025 Jul 1;28(8):113029. doi: 10.1016/j.isci.2025.113029. eCollection 2025 Aug 15.
2
Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer.肝癌分子认识、早期检测及靶向治疗的进展与挑战
World J Hepatol. 2025 Jan 27;17(1):102273. doi: 10.4254/wjh.v17.i1.102273.
3
Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma: An In-Depth Review.
探讨β-连环蛋白突变在肝细胞癌中的作用:深入综述。
Cancer Control. 2024 Jan-Dec;31:10732748241293680. doi: 10.1177/10732748241293680.
4
Specific features of ß-catenin-mutated hepatocellular carcinomas.β-连环蛋白突变型肝细胞癌的特异性特征。
Br J Cancer. 2024 Dec;131(12):1871-1880. doi: 10.1038/s41416-024-02849-7. Epub 2024 Sep 11.
5
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine.靶向Wnt-β-连环蛋白信号通路用于肝癌纳米医学
Gastro Hep Adv. 2023 Jul 20;2(7):948-963. doi: 10.1016/j.gastha.2023.07.012. eCollection 2023.
6
Phospholipid isotope tracing suggests β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma.磷脂同位素示踪表明β-连环蛋白驱动的肝癌中磷脂酰胆碱代谢抑制。
Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Aug;1869(6):159514. doi: 10.1016/j.bbalip.2024.159514. Epub 2024 May 23.
7
Phospholipid isotope tracing reveals β-catenin-driven suppression of phosphatidylcholine metabolism in hepatocellular carcinoma.磷脂同位素示踪揭示β-连环蛋白驱动的肝细胞癌中磷脂酰胆碱代谢抑制
bioRxiv. 2023 Oct 16:2023.10.12.562134. doi: 10.1101/2023.10.12.562134.
8
Glucose-induced and ChREBP: MLX-mediated lipogenic program promotes hepatocellular carcinoma development.葡萄糖诱导的以及ChREBP:MLX介导的脂肪生成程序促进肝细胞癌的发展。
Oncogene. 2023 Oct;42(43):3182-3193. doi: 10.1038/s41388-023-02831-2. Epub 2023 Sep 9.
9
A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of .一种由二乙基亚硝胺诱导并伴有……缺失的新型肝细胞-胆管癌联合小鼠模型
Cancers (Basel). 2023 Aug 21;15(16):4193. doi: 10.3390/cancers15164193.
10
Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma.Ras丝裂原活化蛋白激酶信号传导与Ras激酶抑制因子作为肝细胞癌的治疗靶点
J Liver Cancer. 2021 Mar;21(1):1-11. doi: 10.17998/jlc.21.1.1. Epub 2021 Mar 31.